These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31748878)

  • 1. Identification of GIMAP7 and Rabl3 as Putative Biomarkers for Oral Squamous Cell Carcinoma Through Comparative Proteomic Approach.
    Usman M; Ilyas A; Hashim Z; Zarina S
    Pathol Oncol Res; 2020 Jul; 26(3):1817-1822. PubMed ID: 31748878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
    Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
    Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
    Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Markers from Serum-Purified Exosomes for Detecting Oral Squamous Cell Carcinoma Metastasis.
    Li C; Zhou Y; Liu J; Su X; Qin H; Huang S; Huang X; Zhou N
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1668-1681. PubMed ID: 31350263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Proteomic Analysis of Non-Tobacco Associated Oral Squamous Cell Carcinoma Reveals Deregulation of Cytoskeletal and Apoptotic Proteins.
    T A S; Narayan M; Krishnan R; Thayalan D; Gunasekaran N; S P
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4285-4292. PubMed ID: 36580011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum HSP90-Alpha and Oral Squamous Cell Carcinoma: A Prospective Biomarker.
    Usman M; Ilyas A; Syed B; Hashim Z; Ahmed A; Zarina S
    Protein Pept Lett; 2021; 28(10):1157-1163. PubMed ID: 34137356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Differentially Expressed Proteins from Smokeless Tobacco Addicted Patients Suffering from Oral Squamous Cell Carcinoma.
    Malik UU; Siddiqui IA; Ilyas A; Hashim Z; Staunton L; Kwasnik A; Pennington SR; Zarina S
    Pathol Oncol Res; 2020 Jul; 26(3):1489-1497. PubMed ID: 31446608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis.
    Liu Y; Tan YR; Sun WW; Ju WT; Fu Y; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
    Proteomics Clin Appl; 2018 Sep; 12(5):e1700180. PubMed ID: 29461673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand.
    Chanthammachat P; Promwikorn W; Pruegsanusak K; Roytrakul S; Srisomsap C; Chokchaichamnankit D; Svasti J; Boonyaphiphat P; K S; Thongsuksai P
    Arch Oral Biol; 2013 Nov; 58(11):1677-85. PubMed ID: 24112734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma.
    Wang Z; Jiang L; Huang C; Li Z; Chen L; Gou L; Chen P; Tong A; Tang M; Gao F; Shen J; Zhang Y; Bai J; Zhou M; Miao D; Chen Q
    Mol Cell Proteomics; 2008 Sep; 7(9):1639-50. PubMed ID: 18458027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
    Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
    J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
    Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
    J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma.
    Tung CL; Lin ST; Chou HC; Chen YW; Lin HC; Tung CL; Huang KJ; Chen YJ; Lee YR; Chan HL
    J Pharm Biomed Anal; 2013 Mar; 75():7-17. PubMed ID: 23312379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The overexpression of Rabl3 is associated with pathogenesis and clinicopathologic variables in hepatocellular carcinoma.
    Pan Y; Liu Z; Feng Z; Hui D; Huang X; Tong D; Jin Y
    Tumour Biol; 2017 Apr; 39(4):1010428317696230. PubMed ID: 28443498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential glycoprotein biomarkers in oral squamous cell carcinoma using sweet strategies.
    Wong YL; Anand R; Yuen KM; Mustafa WMW; Abraham MT; Tay KK; Rahman ZAA; Chen Y
    Glycoconj J; 2021 Feb; 38(1):1-11. PubMed ID: 33547992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Label-free tissue proteomics can classify oral squamous cell carcinoma from healthy tissue in a stage-specific manner.
    Dickinson A; Saraswat M; Mäkitie A; Silén R; Hagström J; Haglund C; Joenväärä S; Silén S
    Oral Oncol; 2018 Nov; 86():206-215. PubMed ID: 30409303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma.
    An J; Liu Z; Liang Q; Pan Y; Li H; Wang R; Jin Y
    Hum Pathol; 2017 Sep; 67():146-151. PubMed ID: 28739496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
    Liu Y; Li R; Ren G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach.
    Koike H; Uzawa K; Nakashima D; Shimada K; Kato Y; Higo M; Kouzu Y; Endo Y; Kasamatsu A; Tanzawa H
    Int J Oncol; 2005 Jul; 27(1):59-67. PubMed ID: 15942644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.